This compound is a pharmaceutical intermediate used in the manufacture of varenicline. It is a trifluoroacetyl-protected dinitro derivative with a fused tricyclic ring system containing both aromatic and aliphatic components.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(3S,4R)-3-fluoro-1-methyl-piperidin-4-amine;dihydrochloride
pharmaceutical intermediate
Tert-butyl (3R)-4,4-difluoro-3-hydroxy-piperidine-1-carboxylate
pharmaceutical intermediate
(3R,4S)-3-Fluoro-1-methylpiperidin-4-amine dihydrochloride
pharmaceutical intermediate
1-(2-Chloro-5-nitrophenyl)ethanone
pharmaceutical intermediate
2,3,4,5-Tetrahydro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine-7,8-diamine
research compound
2,3,4,5-Tetrahydro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine
research compound
2,3,4,5-tetrahydro-1,5-methano-1H-3-benzazepine hydrochloride
research compound
The international HS code for 1-(7,8-Dinitro-1,2,4,5-tetrahydro-3H-1,5-methano-3-benzazepin-3-yl)-2,2,2-trifluoroethan-1-one (CAS 230615-59-5) is 2933.39.
2933.39
2933 39 99
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
1-(4,5-dinitro-10-azatricyclo[6.3.1.02,7]dodeca-2,4,6-trien-10-yl)-2,2,2-trifluoroethanone
BDTXJBWOCIFUMR-UHFFFAOYSA-N
C1C2CN(CC1C3=CC(=C(C=C23)[N+](=O)[O-])[N+](=O)[O-])C(=O)C(F)(F)F
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.